IMPACT OF CLINICAL PHARMACIST ON â??PATIENTS CAREâ? IN ACUTE CORONARY SYNDROME

This is a single blinded interventional research in which patient were regularly followed-up. First Intervention includes collecting data to analyze cost of therapy which includes cost minimization by prescribing cheap brands/generics (pharmacoeconomics), quality of life of the patients was measured by WHO QOL BREF questionnaire as outcome of Intervention and second is early ADR detection and prevention and life style modification. The overall mean score of WHO QOL BREF questionnaire of all recruited patients at the time of admission was 30.39 which comparatively increased to 58.45 at the time of discharge. The total cumulative therapy cost was accounted Rs.451, 320.98 for all 65 patients included in the study. The average no. of drugs prescribed per prescription were approximately 7 drugs and 6 drugs in generic name and as per WHO essential list respectively. Patient counseling and life style modifications in addition to treatment showed significant evidence in improvement of patients’ therapeutic outcomes, improved quality of life.